radiofrequency catheter ablation
ProcedureIn this arm, catheter ablation would be performed in the left atrium and would include pulmonary vein isolation and linear ablations (roof and mitral isthmus lines)
NCT Number: NCT01711047
The optimal strategy for catheter ablation of persistent atrial fibrillation is not clearly defined. This study investigates if Complex Fractionated Atrial Electrogram (CFAE) ablation in addition to pulmonary vein isolation and linear ablations improves single procedural success rate over a 12 month follow up period.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Royal Bournemouth Hospital, Bournemouth, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this arm, catheter ablation would be performed in the left atrium and would include pulmonary vein isolation and linear ablations (roof and mitral isthmus lines)
Time frame: 12 MONTHS
Time frame: 12 months after last ablation
Time frame: 30 days of procedure
Time frame: Time 0
This information will be recorded immediately after the procedure.
Time frame: 12 months after the last procedure
Time frame: Time 0
This information will be recorded immediately after the procedure.
Time frame: Time 0
This information will be recorded immediately after the procedure
Oxford University Hospitals NHS Trust
Other
A Study to Investigate the Benefit Of Complex Fractionated Atrial Electrogram (CFAE) Ablation in Addition to Circumferential Pulmonary Vein and Linear Ablations in the Treatment of Persistent Atrial Fibrillation. (BOCA)
Acronym: BOCA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05085860
Arrhythmias, Cardiac, Atrial Fibrillation
Ottawa, Ontario, Canada
View Trial DetailsNCT06223789
Arrhythmias, Cardiac, Atrial Arrhythmia
Birmingham, Alabama, United States
View Trial DetailsNCT04061603
Arrhythmias, Cardiac, Atrial Fibrillation
Birmingham, Alabama, United States
View Trial DetailsNCT04111731
Arrhythmias, Cardiac, Atrial Fibrillation
Liverpool, United Kingdom
View Trial Details